Press Releases for CPHD

Press Releases
Cepheid to Webcast Upcoming Financial Presentations
Cepheid Reports 2009 Second Quarter Results
BenchmarkJournal.Com Free Analyst Review for SWHC, AMAT, SYNA, VRTX, CPHD and AKAM
Cepheid Receives FDA Clearance for First On-Demand Molecular Diagnostic Test for Clostridium difficile Infection
Cepheid Schedules 2009 Second Quarter Financial Results Announcement and Webcast
New England Journal of Medicine Study Highlights Need for Rapid, PCR-based Group B Streptococcus (GBS) Testing at Time of Admission for Labor and Delivery
Cepheid Announces European Release of Improved Test for BCR-ABL Chromosomal Translocation Associated With Chronic Myelogenous Leukemia (CML)
Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System
Cepheid Announces Symposium Program for 2009 Association for Professionals in Infection Control (APIC) Annual Conference
Cepheid Receives Health Canada License for Xpert(R) HemosIL(R) FII & FV Test
Blue Mountain Quality Resources Announces that Cepheid has Selected Blue Mountain Regulatory Asset Manager
Cepheid to Webcast Upcoming Financial Presentations
Cepheid Announces Symposium Speakers and Program Highlights for 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin
Cepheid Reports 2009 First Quarter Results
Cepheid Reports 2009 First Quarter Results
Cepheid Schedules Fiscal 2009 First Quarter Financial Results Announcement and Webcast
Cepheid Announces European Release of First On-Demand Molecular Pre-Surgical Screening Test for Simultaneous Detection of Methicillin-Sensitive and Resistant S. aureus
Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB)
Cepheid Receives Health Canada License for First On-demand Diagnostic Test for Life-threatening MRSA and S. aureus Infections From Patient Positive Blood Culture Bottles
Cepheid Reports Fourth Quarter and Full Year 2008 Results
Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
Cepheid to Webcast Upcoming Financial Presentations - Dec 4 2008 8:42PM
Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S. aureus Soft Tissue Infections
Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
Cepheid to Webcast Upcoming Financial Presentations
Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA
Cepheid Accelerates Direct Sales Channel in UK With Pending Acquisition of Medical Distributor Stretton Scientific
Cepheid Reports Third Quarter Revenue of $44.9 Million
Results of United Kingdom MRSA Surveillance Program Using Cepheid GeneXpert(R) System Demonstrate Benefits of Rapid Testing
Cepheid Molecular Diagnostic Test for MRSA and S. aureus Categorized 'Moderate Complexity' by FDA
Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection
Cepheid Schedules Fiscal 2008 Third Quarter Financial Results Announcement and Webcast
Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus
California Legislation Highlights Need for Broad Menu of Tests in Growing Healthcare Acquired Infection Market
Cepheid to Webcast Upcoming Financial Presentations - Aug 22 2008 8:46AM
BeaconEquity.com Issues Technical Trade Alerts on Market Movers: YHOO, GOOG, DENN, RFMD, TRID, CPHD
Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting
Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of 'Start Clean' Strategy
Cepheid Reports Second Quarter Revenue of $42.1 Million
Cepheid to Webcast Analyst Event
Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast
Noted Molecular Epidemiologist Joins Cepheid to Head Healthcare Associated Infection Consortium Program
Cepheid Management to Present at the 7th Annual Needham Medical Technology and Biotechnology Conference and William Blair's 28th Annual Growth Stock Conference
Cepheid Market Reach Extended with Licenses in Canada and Registrations in Mexico
Cepheid Signs Group Purchasing Contract with Novation, the Nation's Largest Healthcare Contracting Organization - May 27 2008 1:28AM
Cepheid Signs Group Purchasing Contract With Premier Healthcare Alliance, One of the Largest U.S. Group Purchasing Organizations - Jun 1 2008 4:43PM
Breaking News Alert: UDTT! - May 27 2008 12:50AM
Cepheid to Present at the Robert W. Baird Growth Stock Conference and the Bank of America Healthcare Conference - Jun 1 2008 4:43PM
Cepheid Reports Record Revenue of $44.8 Million - Jun 1 2008 4:43PM
BellwetherReport.com Initiates Analyst Coverage on CPHD, STSA, CYTR and NKTR
Cepheid Schedules Teleconference and Webcast for First Quarter 2008 Results
Cepheid Selected as Vendor of Choice by Connecticut Hospital Association Shared Services Program for Molecular MRSA Surveillance Testing